Kartik Raj, Western Europe researcher, works on a wide range of human rights issues with a particular focus on the human rights dimensions of poverty and inequality in the region ...

Merck to pay as much as $22 billion for Daiichi Sankyo’s cancer drugs Oct. 20, 2023 Updated Fri., Oct. 20, 2023 at 8:37 p.m. Merck & Co. headquarters is shown in Kenilworth, N.J., on Jan. 25, 2021.

In a long-running patent case against pharma giant Novartis, Daiichi Sankyo has secured a key win in the U.S. District Court for the Northern District of California. | In a patent infringement ...

Japan's Daiichi Sankyo announced on Friday a $5.5 billion agreement with Merck to jointly develop its three precision cancer drug candidates, in a deal that could generate $16 billion more ...

(Reuters) - The U.S. Food and Drug Administration declined to approve Merck and Japan-based Daiichi Sankyo's lung cancer treatment, which belongs to a lucrative class of cancer therapies that work ...